Market Research Logo

Patient Derived Xenograft/PDX Models

Patient Derived Xenograft/PDX Models

Patient Derived Xenograft/PDX Models market worldwide is projected to grow by US$176.1 Million, driven by a compounded growth of 17.1%. Mouse, one of the segments analyzed and sized in this study, displays the potential to grow at over 16.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$178 Million by the year 2025, Mouse will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 18.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$6.9 Million to the region's size and clout in the next 5 to 6 years. Over US$8.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Mouse will reach a market size of US$12.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.8% over the next couple of years and add approximately US$31 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Champions Oncology, Inc.; Charles River Laboratories International, Inc.; Crown Bioscience, Inc.; Epo Berlin-Buch GmbH; Hera BioLabs; Oncodesign; Pharmatest Services Ltd.; The Jackson Laboratory; Urolead SAS; WuXi AppTec; Xentech

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Patient Derived Xenograft/PDX Models Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Patient Derived Xenograft/PDX Models Global Market Estimates and Forecasts in US$ by Region/Country: 2018-2025
TABLE 2: Patient Derived Xenograft/PDX Models Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
TABLE 3: Pre-Clinical Drug Development (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2018-2025
TABLE 4: Pre-Clinical Drug Development (Application) Market Share Breakdown by Region/Country: 2019 VS 2025
TABLE 5: Basic Cancer Research (Application) Demand Potential Worldwide in US$ by Region/Country: 2018-2025
TABLE 6: Basic Cancer Research (Application) Share Breakdown Review by Region/Country: 2019 VS 2025
TABLE 7: Mouse (Type) World Market by Region/Country in US$: 2018 to 2025
TABLE 8: Mouse (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
TABLE 9: Rat (Type) Potential Growth Markets Worldwide in US$: 2018 to 2025
TABLE 10: Rat (Type) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
TABLE 11: Pharma & Biotech (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2018-2025
TABLE 12: Pharma & Biotech (End-Use) Distribution of Global Sales by Region/Country: 2019 VS 2025
TABLE 13: CRO (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2018 through 2025
TABLE 14: CRO (End-Use) Global Market Share Distribution by Region/Country for 2019 and 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Patient Derived Xenograft/PDX Models Market Share (in %) by Company: 2019 & 2025
TABLE 15: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by Application: 2018 to 2025
TABLE 16: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by Application: 2019 VS 2025
TABLE 17: United States Patient Derived Xenograft/PDX Models Market Estimates and Projections in US$ by Type: 2018 to 2025
TABLE 18: United States Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
TABLE 19: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by End-Use: 2018 to 2025
TABLE 20: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by End-Use: 2019 VS 2025
CANADA
TABLE 21: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2018 to 2025
TABLE 22: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
TABLE 23: Canadian Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018 to 2025
TABLE 24: Patient Derived Xenograft/PDX Models Market in Canada: Percentage Share Breakdown of Sales by Type for 2019 and 2025
TABLE 25: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2018 to 2025
TABLE 26: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025
JAPAN
TABLE 27: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
TABLE 28: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by Application: 2019 VS 2025
TABLE 29: Japanese Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2018-2025
TABLE 30: Japanese Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
TABLE 31: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
TABLE 32: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by End-Use: 2019 VS 2025
CHINA
TABLE 33: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
TABLE 34: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2019 VS 2025
TABLE 35: Chinese Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2018-2025
TABLE 36: Chinese Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2019 and 2025
TABLE 37: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
TABLE 38: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2019 VS 2025
EUROPE
Market Facts & Figures
European Patient Derived Xenograft/PDX Models Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 39: European Patient Derived Xenograft/PDX Models Market Demand Scenario in US$ by Region/Country: 2018-2025
TABLE 40: European Patient Derived Xenograft/PDX Models Market Share Shift by Region/Country: 2019 VS 2025
TABLE 41: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2018-2025
TABLE 42: European Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
TABLE 43: European Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018-2025
TABLE 44: European Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
TABLE 45: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2018-2025
TABLE 46: European Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025
FRANCE
TABLE 47: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by Application: 2018-2025
TABLE 48: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
TABLE 49: Patient Derived Xenograft/PDX Models Market in France by Type: Estimates and Projections in US$ for the Period 2018-2025
TABLE 50: French Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
TABLE 51: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by End-Use: 2018-2025
TABLE 52: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025
GERMANY
TABLE 53: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2018-2025
TABLE 54: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by Application: 2019 VS 2025
TABLE 55: Patient Derived Xenograft/PDX Models Market in Germany: Recent Past, Current and Future Analysis in US$ by Type for the Period 2018-2025
TABLE 56: German Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
TABLE 57: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2018-2025
TABLE 58: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by End-Use: 2019 VS 2025
ITALY
TABLE 59: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
TABLE 60: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2019 VS 2025
TABLE 61: Italian Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2018-2025
TABLE 62: Italian Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2019 and 2025
TABLE 63: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
TABLE 64: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2019 VS 2025
UNITED KINGDOM
TABLE 65: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2018 to 2025
TABLE 66: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by Application: 2019 VS 2025
TABLE 67: United Kingdom Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2018-2025
TABLE 68: United Kingdom Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
TABLE 69: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2018 to 2025
TABLE 70: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by End-Use: 2019 VS 2025
REST OF EUROPE
TABLE 71: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2018-2025
TABLE 72: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
TABLE 73: Rest of Europe Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018-2025
TABLE 74: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2019 VS 2025
TABLE 75: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2018-2025
TABLE 76: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025
ASIA-PACIFIC
TABLE 77: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2018-2025
TABLE 78: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
TABLE 79: Patient Derived Xenograft/PDX Models Market in Asia-Pacific by Type: Estimates and Projections in US$ for the Period 2018-2025
TABLE 80: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2019 VS 2025
TABLE 81: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2018-2025
TABLE 82: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025
REST OF WORLD
TABLE 83: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2018 to 2025
TABLE 84: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2019 VS 2025
TABLE 85: Rest of World Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2018 to 2025
TABLE 86: Patient Derived Xenograft/PDX Models Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2019 and 2025
TABLE 87: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2018 to 2025
TABLE 88: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2019 VS 2025
IV. COMPETITION
CHAMPIONS ONCOLOGY
CHARLES RIVER LABORATORIES INTERNATIONAL
CROWN BIOSCIENCE
EPO BERLIN-BUCH GMBH
HERA BIOLABS
ONCODESIGN
PHARMATEST SERVICES LTD.
THE JACKSON LABORATORY
UROLEAD SAS
WUXI APPTEC
XENTECH
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report